Want to find Targeted B2B leads? Slice and dice from over 84 million business prospects across 675+ industries, 400+ technologies, ad spend, and much more. Try it now for FREE!

How it works video / FAQ



Company Description: ALK Corporate website - World leader in allergy vaccination - ALK treats the cause of allergy

1700 Royston Lane Round Rock, Texas 78664 United States
(512) 251-0037 (512) 251-8450 Fax

Industries: Startups

Technologies: ALK-Abelló is using 6 Technologies.

Social Media: ALK-Abelló has 56 social media shares and likes.

We have 10 emails for ALK-Abelló.

Social Media

Web Server Technology

Nginx is a popular open source web server for high-traffic websites, providing fast, scalable, efficient application delivery for both web and mobile
Internet Information Services (IIS) for Windows Server is a flexible, secure and manageable Web server used for hosting anything on the internet.

Frameworks Technology

ASP.net is a free web framework for creating websites, apps, and services using HTML, CSS and JavaScript
Microsoft Office SharePoint
is a web application framework and platform developed by Microsoft. First launched in 2001,[3] SharePoint integrates intranet, content management and document management, but recent versions have broader capabilities.[
Telerik is a market-leading vendor of UI controls, end-to-end solutions for mobile app development, ALM tools across all major development platforms.

duplicate Technology

Additional Info and Employees

ALK is a global research-driven pharmaceutical company that focuses on prevention, diagnosis and treatment of allergies.


Jens Bager
President, CEO at ALK Abelló

Henrik Jacobi
EVP, Research & Development at ALK Abelló

Flemming Pedersen
CFO, EVP Finance at ALK Abelló

Søren Niegel
EVP, Commercial Operations at ALK Abelló

alk-abello.com Emails

Sign up to get full access to all the alk-abello.com emails we have.





Find emails for ALK-Abelló executives, including the Chief Executive Officer, Chief Financial Officer, and Chief Marketing Officer.